highly significantP <0.001
However, saroglitazar treatment (2 mg/kg/day, PO) could significantly reduce TGs ( P <0.01), and saroglitazar (4 mg/kg/day, PO) produced highly significant ( P <0.001) reduction in MSG rats.
However, saroglitazar treatment (2 mg/kg/day, PO) could significantly reduce TGs ( P <0.01), and saroglitazar (4 mg/kg/day, PO) produced highly significant ( P <0.001) reduction in MSG rats.